EC: Guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use - Draft

14.02.2013

These guidelines provide guidance on how to asses and rank the risk presented by the excipient, cover identification on appropriate GMP and assesment and present guidance on how to manage the risks of use of the excipient on an on-going basis.